RETRACTED: Association between sarcoidosis and cardiovascular Outcomes: A systematic review and Meta-analysis

Doughan, 2006, Cardiac sarcoidosis, Heart, 92, 282, 10.1136/hrt.2005.080481 Kim, 2009, Cardiac sarcoidosis, Am. Heart J., 157, 9, 10.1016/j.ahj.2008.09.009 Criado, 2010, Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation, Radiographics, 30, 1567, 10.1148/rg.306105512 M. Veltkamp, J.C. Grutters, The pulmonary manifestations of sarcoidosis, in: Pulmonary Sarcoidosis. Springer; 2014. p. 19–39. Belperio, 2021, Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement, EClinicalMedicine, 37, 100966, 10.1016/j.eclinm.2021.100966 Cardiac Sarcoidosis - Ottawa Heart Institute [Internet]. [cited 2022 Apr 10]. Available from: https://www.ottawaheart.ca/heart-condition/cardiac-sarcoidosis. Cox, 2005, Sarcoidosis, Med. Clin. North Am., 89, 817, 10.1016/j.mcna.2005.02.006 Matsui, 1976, Clinicopathological study of fatal myocardial sarcoidosis, Ann. N. Y. Acad. Sci., 278, 455, 10.1111/j.1749-6632.1976.tb47058.x Kandolin, 2015, Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study, Circulation, 131, 624, 10.1161/CIRCULATIONAHA.114.011522 Birnie, 2016, Cardiac Sarcoidosis, J. Am. Coll. Cardiol., 68, 411, 10.1016/j.jacc.2016.03.605 Youssef, 2011, Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment, Heart, 97, 2078, 10.1136/hrt.2011.226076 Patel, 2009, Detection of myocardial damage in patients with sarcoidosis, Circulation, 120, 1969, 10.1161/CIRCULATIONAHA.109.851352 Yatsynovich, 2018, Cardiac sarcoidosis: a review of contemporary challenges in diagnosis and treatment, Am. J. Med. Sci., 355, 113, 10.1016/j.amjms.2017.08.009 Gilotra, 2020, Management of cardiac sarcoidosis in 2020, Arrhythm Electrophysiol. Rev., 9, 182, 10.15420/aer.2020.09 Roberts, 1977, Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11), Am. J. Med., 63, 86, 10.1016/0002-9343(77)90121-8 Jaiswal, 2022, Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: a systematic review and proportion meta-analysis, Ann. Med. Surg. (Lond), 76, 103429, 10.1016/j.amsu.2022.103429 Jaiswal, 2022, Hypovitaminosis D and cardiovascular outcomes: a systematic review and meta-analysis, Int. J. Cardiol. Heart Vasc., 40, 101019 DerSimonian, 1986, Meta-analysis in clinical trials, Control. Clin. Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Chandler, 2013, Cochrane methods–twenty years experience in developing systematic review methods, Syst Rev., 2, 76, 10.1186/2046-4053-2-76 StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC 2021. G. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos et al. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. Available from: http://www.ohri.ca/programs/clinical_epidemiology/ oxford.htm. Yafasova, 2020, Long-term adverse cardiac outcomes in patients with sarcoidosis, J. Am. Coll. Cardiol., 76, 767, 10.1016/j.jacc.2020.06.038 Rosenthal, 2021, Heart failure, atrioventricular block, and ventricular tachycardia in sarcoidosis, J. Am. Heart Assoc., 10, 10.1161/JAHA.120.017692 Nery, 2014, Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults, J. Cardiovasc. Electrophysiol., 25, 875, 10.1111/jce.12401 Rossides, 2022, Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden, Heart, 108, 467, 10.1136/heartjnl-2021-319129 Ungprasert, 2017, Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, Eur. Respir. J., 49, 1601290, 10.1183/13993003.01290-2016 Te, 2017, Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up, Int. J. Cardiol., 228, 68, 10.1016/j.ijcard.2016.11.041 Wu, 2017, Comorbid autoimmune diseases in patients with sarcoidosis: a nationwide case-control study in Taiwan, J. Dermatol., 44, 423, 10.1111/1346-8138.13654 Beghè, 2017, Sarcoidosis in an Italian province. Prevalence and environmental risk factors, PLoS ONE, 12, e0176859, 10.1371/journal.pone.0176859 Tuleta, 2017, Impaired Vascular Function in Sarcoidosis Patients, Adv. Exp. Med. Biol., 980, 1, 10.1007/5584_2016_203 Mahmoud, 2020, Association between sarcoidosis and cardiovascular comorbidity: a systematic review and meta-analysis, Heart Lung, 49, 512, 10.1016/j.hrtlng.2020.03.013 Hamzeh, 2015, Pathophysiology and clinical management of cardiac sarcoidosis, Nat. Rev. Cardiol., 12, 278, 10.1038/nrcardio.2015.22 Iwai, 1993, Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern, Acta Pathol Jpn., 43, 377 Kandolin, 2011, Diagnosing isolated cardiac sarcoidosis, J. Intern. Med., 270, 461, 10.1111/j.1365-2796.2011.02396.x Baughman, 2021, ERS clinical practice guidelines on treatment of sarcoidosis, Eur. Respir. J., 58, 10.1183/13993003.04079-2020 Viles-Gonzalez, 2013, Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications, Chest, 143, 1085, 10.1378/chest.11-3214 Desai, 2018, The burden of cardiac arrhythmias in sarcoidosis: a population-based inpatient analysis, Ann. Transl. Med., 6, 330, 10.21037/atm.2018.07.33 Etinger, 2021, The long-term prognostic significance of heart failure in sarcoidosis patients horizontal line a cohort study, Postgrad. Med., 133, 202, 10.1080/00325481.2020.1832773 Gonen, 2021, The association between sarcoidosis and ischemic heart disease-A healthcare analysis of a large Israeli population, J. Clin. Med., 10, 5067, 10.3390/jcm10215067 Yazaki, 2001, Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone, Am. J. Cardiol., 88, 1006, 10.1016/S0002-9149(01)01978-6